News

Acquisition Enriches Medidata’s Comprehensive Risk-Based Monitoring Solution, Enabling Safer, Faster and More Insightful Clinical Trial Reviews

SCRS announced a two-year collaboration with Clinical Ink

Medidata announced the availability is enriched solution for risk-based monitoring.

PCORI is launching a $50 million program to fund research on the comparative effectiveness of various approaches for diagnosing and treating hepatitis C.

TrialScope announced the latest release of its PharmaCM platform (v.2.2)

TrialScope announced general availability of the latest release of the PharmaCM platform

Comprehend CEO Rick Morrison shares his thoughts on 2015 predictions for clinical R&D.

The conclusions on vaccination that European Union health ministers adopted on December 1 contain several sound thoughts.

Company to fund new SCRS Scholarship Program to improve site sustainability through education; becomes first CRO to leverage Site Advocacy Group to improve clinical development process

Biorasi LLC announced that it has completed the acquisition of Advanced Biosciences Research

Leading Global CRO Expands into Western Europe, Establishes its European Headquarters in Frankfurt, Germany

BBK Worldwide and ACRES are collaborating to ensure that patients are a central part of the organization's efforts in standards development

For each clinical trial, a clinical trial agreement and budget are negotiated between the investigator and the sponsoring company so that the costs of carrying out the trial are reimbursed.

Global packaging company has received a grant from The Bill & Melinda Gates Foundation to improve adherence and accuracy during PrEP trials

Performer platform enables users to benchmark clinical trial performance against industry standards, assess key drivers of performance, and provide predictive analytics

CRO Analytics announced that it is seeking sponsor and CRO partners to enroll in a limited Pilot to Production program

Global packaging company has received a grant from The Bill & Melinda Gates Foundation to improve adherence and accuracy during PrEP trials

There is a lot of discussion and awareness on the topic of patient centricity, as many experts are starting to discuss how the concept can improve clinical trials.

The drug industry has seen an increasing movement to leverage mobile technology to engage with patients and collect their data during clinical trials.

It is tempting to imagine the use of the patient's own mobile computing platform for collection of patient-reported outcomes (PROs).

The promise is that customized delivery of injectible drugs and biologics will reduce toxicity, enhance individual response, facilitate the delivery of multiple drugs, minimize waste, and encourage patient adherence to prescribed treatment.

As the importance of translational research continues to grow, research institutions are exploring other options to remain competitive players in the academic clinical research arena.

The Future of ePRO Collection Mobile Customization Strategies Academic Research and CTMS Also in this issue: New Combination Drug Challenges Clinical Research Perceptions in Europe Key Benefits of Investigator Portals